Johnson & Johnson (NYSE:JNJ) reportedly won the 1st lawsuit to go to trial over its Prosima pelvic mesh implant, after a Texas state jury ruled yesterday that the device was not defectively designed and that J&J subsidiary Ethicon’s risk warnings were adequate.
The Dallas County District Court jury’s 10-2 verdict rejected claims by plaintiff Carol Cavness that Ethicon’s Gynecare Prosima device, implanted to treat her pelvic organ prolapse, caused her injuries, according to Court TV News, HarrisMartin Publishing and Law360.
Cavness had asked Judge Ken Molberg to award $9.5 million for past and future medical expenses and pain & suffering, and an unspecified amount of punitive damages.
Ethicon spokesman Matthew Johnson said in a statement that the jury’s decision “reflects the facts in this case” and that Ethicon acted appropriately and responsibly in the research, development and marketing of the Prosima mesh, Courtroom View Network reported.
“We empathize with all women suffering from pelvic organ prolapse, which can be a serious and debilitating condition, and we are always concerned when a patient experiences adverse medical events,” Johnson told the website.